Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer-Reference-Cited by-同舟云学术

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer

Published:2020-03 Issue:3 Volume:37 Page:289-307.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Hegde Samarth,Krisnawan Varintra E.,Herzog Brett H.,Zuo Chong,Breden Marcus A.,Knolhoff Brett L.,Hogg Graham D.,Tang Jack P.,Baer John M.,Mpoy Cedric,Lee Kyung Bae,Alexander Katherine A.,Rogers Buck E.,Murphy Kenneth M.,Hawkins William G.,Fields Ryan C.,DeSelm Carl J.,Schwarz Julie K.,DeNardo David G.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference109 articles.

1. Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity;Ager;Cancer Immunol. Res.,2017

2. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression;Alam;Nat. Med.,2015

3. Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma;Bailey;Sci. Rep.,2016

4. Genomic analyses identify molecular subtypes of pancreatic cancer;Bailey;Nature,2016

5. Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors;Baird;Cancer Res.,2016

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs;International Immunopharmacology;2024-11

2. Deciphering single-cell transcriptomic landscape of tumors in colorectal cancer treated with photothermal semiconducting polymers to design the combination therapy with checkpoint blockades for inhibition of tumor progression and metastasis;Nano Today;2024-10

3. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

4. ZG16 enhances the maturation of dendritic cells via induction of CD40 and contributes to the antitumor immunity in pancreatic cancer;Oncogene;2024-09-11

5. Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer;Journal of Clinical Oncology;2024-09-10